Key Takeaways:
- UpTerra names Dr. Shiv Tiwari as Chief Science Officer to lead scientific strategy and product advancement
- Dr. Tiwari will drive innovation for TerraFlow, UpTerra’s flagship irrigation water optimization technology
- TerraFlow uses patent-pending vortexing and frequency imprinting to improve plant absorption and reduce waste
- Dr. Tiwari brings extensive biotechnology experience from GreenVenus, Corteva, and Intrexon
- His research contributions include more than 25 publications, 6,000 citations, and over a dozen patents
UpTerra strengthens leadership with new Chief Science Officer
UpTerra, a company focused on redefining water performance in agriculture, announced the appointment of Dr. Shiv Tiwari as Chief Science Officer. In his new role, Dr. Tiwari will guide scientific development and innovation for the company’s core technologies, including its flagship product TerraFlow.
Advancing TerraFlow and water efficiency technology
TerraFlow leverages patent-pending vortexing and frequency imprinting technology to enhance the performance of irrigation water. The system improves water uptake and plant absorption, while reducing runoff and evaporation. By making water more effective for crop production, UpTerra aims to help growers increase efficiency and sustainability across agricultural operations.
Dr. Tiwari described his vision for the company, stating, “To me UpTerra turns water into a force for global food productivity, soil renewal, and healthier animals — and planet.”
A leader in plant and animal sciences
With more than 6,000 citations and over 25 scientific publications, Dr. Tiwari is among the most cited researchers in plant and animal sciences. He holds over a dozen patents, including innovations at Corteva (formerly DuPont Pioneer) that improved regeneration and transformation in hardy corn varieties, accelerating seed development.
Extensive industry and academic background
Dr. Tiwari previously served as CEO and CTO at GreenVenus, where he led the company from inception through commercial readiness, advancing regulatory approvals and field trials. His career also includes senior roles at Third Security, Intrexon, Mendel Biotechnology, and Corteva.
In addition to his corporate leadership, Dr. Tiwari has taught at the University of Missouri, Northeastern University, and the Chinese Academy of Agricultural Sciences. He holds a Ph.D. in Life Sciences and an MBA with high honors from Boston University.
